HSP90AB1 and colorectal carcinoma: An example of ABC transporters is P-glycoprotein (P-gp), which pumps foreign molecules outside cells to cause multidrug resistance (MDR); thus, it seems that dual-activity drugs targeting both HSP90 and P-gp have potent activity as anti-CRC therapies.